One Health Group PLC - Full Year Trading Update

One Health Group plc
("One Health", the "Company" or the "Group")
Full Year Trading Update
FY 26 revenue and underlying EBITDA ahead of market expectations
Strong growth across all KPIs
One Health Group plc (AIM: OHGR), the independent provider of NHS-funded surgical procedures for patients referred from the NHS through 'Patient Choice', provides the following trading update for the year ended
Key Highlights
|
|
FY 26
|
FY 25
|
Growth
|
|
Revenue |
|
|
13% |
|
New NHS patient referrals |
18,931 |
17,020 |
11% |
|
Number of consultations |
50,774 |
42,238 |
20% |
|
Number of surgical procedures |
8,113 |
7,043 |
15% |
|
Number of consultants (excluding anaesthetists) |
88 |
80 |
10% |
|
Number of Outreach Clinics |
40 |
37 |
8% |
|
Number of Surgical Operating Facilities |
14 |
10 |
40% |
Surgical Hub progress
· As announced on 23 February, construction of the Company's first Surgical Hub in
· The project is on track to be delivered within the one-year construction period and in line with the previous cost estimate of
· Further locations in underserved areas with high NHS demand continue to be explored for preliminary assessment of suitability for future surgical hubs
Outlook
The Board is confident in the Company's strategy to drive continued organic growth through increased patient referrals, a strong pipeline of new surgeons, and additional surgical capacity in existing and new independent sector hospitals. The Company continues to support the delivery of the challenging NHS waiting list reduction targets set by the Government.
The Company is expected to deliver growth at the revenue and underlying EBITDA levels for FY 26, ahead of market expectations1. Cash at
1Management understands consensus market estimates for revenue and underlying EBITDA for FY 26 to be
"We are delighted to deliver a strong year end trading update ahead of market expectations for our first full year following our AIM listing and that construction of our first surgical hub commenced during this period. NHS national waiting lists remain very high, despite continued NHS efforts and recent modest reductions, and we are proud that One Health remains well-positioned to continue to reduce pressure on the NHS by providing free high-quality care across underserved areas."
If you wish to keep up to date on Company news please email: onehealth@walbrookpr.com
This announcement contains inside information for the purposes of the
and the Directors of the Company are responsible for the release of this announcement.
For more information, please contact:
|
One Health Group plc
|
Via Walbrook PR |
|
|
Panmure Liberum (Nominated Adviser and Broker)
|
Tel: +44 (0)20 3100 2000 |
|
|
Walbrook PR (Media & Investor Relations) |
Tel: +44 (0)20 7933 8780 or onehealth@walbrookpr.com Mob: +44 (0)7407 804 654 / +44 (0)7980 541 893 / +44 (0)7747 515 393 |
|
|
|
||
About One Health Group plc (www.onehealth.co.uk)
One Health engages 88 NHS Consultants (excluding anaesthetists) who sub-specialise in the various surgeries offered by the Company, through a growing network of community-based outreach clinics and surgical operating locations. One Health continues to deliver strong growth and in the year to
One Health's activities are focused on areas where NHS patient needs are under-supplied by the local NHS service, population density is relatively high and the level of private medical insurance or the ability to self-fund is relatively low. Currently, the Company's activities are focused in Yorkshire, Lincolnshire, Derbyshire, Nottinghamshire and Leicestershire. Revenue is derived from 29 ICBs across England as well as contracts with local NHS trusts to transfer their internal waiting list patients to One Health for quicker treatment.
One Health's business model has focused to date on four main areas: orthopaedics, spine, general surgery and gynaecology, with urology introduced at the end of FY25.
Spine and orthopaedics are particularly attractive areas for One Health as the Directors believe that they benefit from powerful growth drivers in terms of an ageing demographic, physical inactivity and an increasing proportion of the population being categorised as obese. Within orthopaedics, the most common surgeries performed by One Health are knee and hip replacements.
Online investor presentation
Click below for the latest online presentation by Derek Bickerstaff, Chairman and Adam Binns, Chief Executive Officer, which offers insights into the Company's growth strategy and long-term vision:
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.
Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.
This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.
In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.
The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.
Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.
From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.
FOR OUR FULL DISCLAIMER CLICK HERE